Prot #C34001: An Open-Label, Dose Escalation, Phase 1, First-in-Human Study of TAK-659 in Adult Patients with Advanced Solid Tumor and Lymphoma Malignancies

Project: Research project

Project Details

Status	Active
Effective start/end date	1/23/14 → 1/23/23